Elicio Therapeutics, Inc. Restricted Cash and Cash Equivalents
Elicio Therapeutics, Inc. (ELTX) had Restricted Cash and Cash Equivalents of $515.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2026-08-13
- 2026-06-30: Restricted Cash and Cash Equivalents $515.00K.
- 2026-03-31: Restricted Cash and Cash Equivalents $706.00K.
- 2025-12-31: Restricted Cash and Cash Equivalents $704.00K.
- 2025-09-30: Restricted Cash and Cash Equivalents $702.00K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2026-06-30 | $515.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $706.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $704.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $702.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $700.00K 10-Q · filed 2026-08-13 |
| 2025-03-31 | $1.38M 10-Q · filed 2026-05-11 |
| 2024-12-31 | $1.87M 10-K · filed 2026-03-12 |
| 2024-09-30 | $2.01M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $1.09M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $1.35M 10-Q · filed 2025-05-13 |
| 2023-12-31 | $1.41M 10-K · filed 2025-03-31 |
| 2023-09-30 | $2.35M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $681.00K 10-Q · filed 2024-08-13 |
| 2023-03-31 | $1.73M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $2.26M 10-K · filed 2024-03-29 |
| 2022-09-30 | $2.77M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $618.00K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |